Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Rat CysLT2 ELISA Kit (AC3113)
Cat.#: ASET-1702
Specifications
Description Rat CysLT2 ELISA Kit allows for the in vitro quantitative determination of rat CysLT2 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Rat Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 0.188 ng/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 0.313-20 ng/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2034 Rat Contactin 1 ELISA Kit (AC3445) Quantitative inquiry ASET-2504 Rat 160 kD Neurofilament Medium ELISA Kit (AC3915) Quantitative inquiry ASET-1373 Human Laminin 2 alpha ELISA Kit (AC2784) Quantitative inquiry ASET-1849 Mouse PTN ELISA Kit (AC3260) Quantitative inquiry ASET-1345 Mouse Prealbumin ELISA Kit (AC2756) Quantitative inquiry ASET-2000 Human CHL1 ELISA Kit (AC3411) Quantitative inquiry ASET-2525 Mouse Acetylcholinesterase ELISA Kit (AC3936) Quantitative inquiry ASET-1937 Mouse GDF6 ELISA Kit (AC3348) Quantitative inquiry ASET-1444 Human SorCS1 ELISA Kit (AC2855) Quantitative inquiry ASET-1933 Human Aldolase C ELISA Kit (AC3344) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket